CN108541947A - 一种叶黄素口服液的制备方法 - Google Patents
一种叶黄素口服液的制备方法 Download PDFInfo
- Publication number
- CN108541947A CN108541947A CN201810398990.7A CN201810398990A CN108541947A CN 108541947 A CN108541947 A CN 108541947A CN 201810398990 A CN201810398990 A CN 201810398990A CN 108541947 A CN108541947 A CN 108541947A
- Authority
- CN
- China
- Prior art keywords
- lutein
- added
- water
- oral solution
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 61
- 239000001656 lutein Substances 0.000 title claims abstract description 59
- 235000012680 lutein Nutrition 0.000 title claims abstract description 59
- 229960005375 lutein Drugs 0.000 title claims abstract description 59
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 title claims abstract description 59
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims abstract description 59
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims abstract description 59
- 229940100688 oral solution Drugs 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 43
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 11
- 238000003756 stirring Methods 0.000 claims description 17
- 239000000049 pigment Substances 0.000 claims description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 2
- VDGJOQCBCPGFFD-UHFFFAOYSA-N oxygen(2-) silicon(4+) titanium(4+) Chemical compound [Si+4].[O-2].[O-2].[Ti+4] VDGJOQCBCPGFFD-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 3
- 230000035699 permeability Effects 0.000 abstract description 3
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 17
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 13
- 238000005303 weighing Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 5
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 235000006010 Bixa orellana Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000030097 organ senescence Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000003093 somatogenic effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000009657 tetraterpenes Nutrition 0.000 description 1
- -1 tetraterpenes compound Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种叶黄素口服液的制备方法,本发明通过加入二氧化硅,利用其提高水中的氢键键合能力,同时加入羊毛醇,利用其自身特性与叶黄素结合后,在二氧化硅的作用下,重组成稳定的组合物,最后在磷脂的作用下,再次结合,同时磷脂为生物膜的组成成分,与细胞膜的结合能力极强,增大整个分子的通透性,提高其生物利用度;通过本发明得到一种制备方法简单、可控适于产业化和规模化的叶黄素口服液的制备方法,同时本发明所得的叶黄素口服液质量稳定且吸收快,具有很好的护眼效果。
Description
技术领域
本发明涉及一种叶黄素口服液的制备方法,属于保健品领域。
背景技术
叶黄素(Lutein),又名植物黄体素、叶黄体,是一类无VA活性的天然类胡萝卜素类(Carotenoids)色素,这种天然色素具有色泽鲜艳、着色力强、安全无毒、抗氧化能力强、预防人体衰老、富有营养而无副作用等优点。其广泛存在于花卉、水果、蔬菜等植物中。叶黄素属于类胡萝卜素类的四萜类化合物。它有两个紫罗兰环,叶黄素的分子式为C40H56O2,分子量为568.85。叶黄素为橙黄色粉末,浆状或深黄棕色液体,有弱的干草气味,不溶于水,溶于丙酮、甲醇、异丙醇、己烷、甲乙酮和二氯甲烷。现在国际上流行将一定量叶黄素添加到食品中制成“叶黄素食品”,可预防人体因器官衰老引起的一系列疾病。大量流行病学证据表明,叶黄素对视觉有保护作用,并具有预防白内障、动脉硬化、增强免疫力等功效。
叶黄素在体内无法合成,需要通过外界吸收来满足身体需求,由于其水溶性差,易氧化等特点,目前国内上市的产品不多,大部分以叶黄素酯为主要原料上市,叶黄素酯性质虽然比叶黄素稳定,但是其分子式大,且在体内需要水解成叶黄素才能吸收起到相应作用,故在利用度方面不如叶黄素好,本发明克服上述的问题,开发一种安全、制备简单、质量稳定的叶黄素口服液。
发明内容
为解决上述现有技术存在的问题,提供一种叶黄素口服液的制备方法,通过本发明中的制备方法,得到的叶黄素口服液稳定,且具有很好的护眼效果。
为了实现上述发明,实施方案如下:
一种叶黄素口服液的制备方法,由以下步骤组成:
1.称取适量水,加热至60-80℃,加入二氧化硅,搅拌1-3小时;
优选的,所述的二氧化过加入质量为水的1-5%。
进一步的,所述的二氧化硅粒径小于10微米;优选小于5微米;
2.加入羊毛醇和叶黄素,继续搅拌1-3小时,保持温度为40-60℃。
优选的,所述的羊毛醇与水的质量比为1:200-500;优选1:300-400。
进一步的,所述的叶黄素与水的质量比为:1:20-40;优选1:30。
3.加入磷脂,搅拌6-10个小时,保持温度为40-60℃。
优选的,所述的磷脂与水的质量比为:1:50-150;优选1:100。
4.加入矫味剂和色素,搅拌混匀,即可。
优选的,所述的矫味剂与色素的总质量为口服液总质量的0.1-1%。
进一步的,所述的矫味剂与色素的质量比为1:1。
进一步的,所述的矫味剂包括蔗糖、甜菊素、阿司帕坦、橘子粉末香精等,优选甜菊素。
进一步的,所述的色素包括日落黄、胭脂树红、胭脂虫红、叶绿素、姜黄素和叶红素等;优选日落黄。
本发明的特点是通过采用二氧化硅提高水中的氢离子亲和力,叶黄素与羊毛醇加入后,叶黄素与羊毛醇在水中氢离子作用下结合,亲水基团外排,与后面的磷脂中的亲水基团结合,形成稳定的组合物,磷脂为生物膜的组成部分,增加组合物的膜通透性。
本发明的有益效果在于:
1.本发明的制备方法简单可控,适于产业化和规模化,能够带来很好的经济效应和社会效应;
2.本发明所得的叶黄素口服液质量稳定,疗效显著,在体内起效快,在护眼方面具有显著效果。
具体实施方式
为了更好的理解本发明要点,现通过具体实施例对上述发明进一步详述,但是下述实施例不能理解为对本发明的进一步限制。
实施例1
一种叶黄素口服液的制备方法,由以下步骤组成:
1.称取适量水,加热至70℃,加入相当于水质量3%的二氧化硅,搅拌1-3小时;
2.加入羊毛醇和叶黄素,羊毛醇与水的质量比为1:350,叶黄素与水的质量比为:1:30,继续搅拌2小时,保持温度为50℃。
3.加入磷脂,磷脂与水的质量比为:1:100,搅拌8个小时,保持温度为50℃。
4.加入甜菊素和日落黄,甜菊素与日落黄的总质量为口服液总质量的0.5%,搅拌混匀,即可。
实施例2
一种叶黄素口服液的制备方法,由以下步骤组成:
1.称取适量水,加热至60℃,加入相当于水质量1%的二氧化硅,搅拌1小时;
2.加入羊毛醇和叶黄素,羊毛醇与水的质量比为1:200,叶黄素与水的质量比为:1:20,继续搅拌1小时,保持温度为40℃。
3.加入磷脂,磷脂与水的质量比为:1:50,搅拌6个小时,保持温度为40℃。
4.加入甜菊素和日落黄,甜菊素与日落黄的总质量为口服液总质量的0.1%,搅拌混匀,即可。
实施例3
一种叶黄素口服液的制备方法,由以下步骤组成:
1.称取适量水,加热至80℃,加入相当于水质量5%的二氧化硅,搅拌3小时;
2.加入羊毛醇和叶黄素,羊毛醇与水的质量比为1:500,叶黄素与水的质量比为:1:40,继续搅拌3小时,保持温度为60℃。
3.加入磷脂,磷脂与水的质量比为:1:150,搅拌10个小时,保持温度为60℃。
4.加入甜菊素和日落黄,甜菊素与日落黄的总质量为口服液总质量的1%,搅拌混匀,即可。
对比实施例1
一种叶黄素口服液的制备方法,由以下步骤组成:
1.称取适量水,加热至70℃,搅拌1-3小时;
2.加入羊毛醇和叶黄素,羊毛醇与水的质量比为1:350,叶黄素与水的质量比为:1:30,继续搅拌2小时,保持温度为50℃。
3.加入磷脂,磷脂与水的质量比为:1:100,搅拌8个小时,保持温度为50℃。
4.加入甜菊素和日落黄,甜菊素与日落黄的总质量为口服液总质量的0.5%,搅拌混匀,即可。
对比实施例2
一种叶黄素口服液的制备方法,由以下步骤组成:
1.称取适量水,加热至70℃,加入相当于水质量3%的二氧化硅,搅拌1-3小时;
2.加入叶黄素,叶黄素与水的质量比为:1:30,继续搅拌2小时,保持温度为50℃。
3.加入磷脂,磷脂与水的质量比为:1:100,搅拌8个小时,保持温度为50℃。
4.加入甜菊素和日落黄,甜菊素与日落黄的总质量为口服液总质量的0.5%,搅拌混匀,即可。
对比实施例3
一种叶黄素口服液的制备方法,由以下步骤组成:
1.称取适量水,加热至70℃,加入相当于水质量3%的二氧化硅,搅拌1-3小时;
2.加入羊毛醇和叶黄素,羊毛醇与水的质量比为1:350,叶黄素与水的质量比为:1:30,继续搅拌2小时,保持温度为50℃。
3.加入甜菊素和日落黄,甜菊素与日落黄的总质量为口服液总质量的0.5%,搅拌混匀,即可。
实施例稳定性考察
取实施例1-3和对比实施例1-3所得的叶黄素口服液,分别倒入100ml高密度聚乙烯瓶
中,密封常温放置,分别在3/6/9/12/24个月时检测其含量,检测方法如下:取个实施例中的
溶液,加水稀释10倍,用721可见分光广度计,以1cm吸收池,441nm作为吸收波长测定其吸
光度,计算溶液稳定性。结果如下:
实施例 | 实施例1 | 实施例2 | 实施例3 | 对比实施例1 | 对比实施例2 | 对比实施例3 |
0月 | 100% | 100% | 100% | 100% | 100% | 100% |
3月 | 98.6% | 99.4% | 99.6% | 87.2% | 90.2 | 98.3% |
6月 | 99.4% | 98.5% | 98.9% | - | - | 96.2% |
9月 | 99.7 | 99.2% | 99.4% | - | - | 92.5% |
12月 | 98.1 | 99.6% | 100.4% | - | - | 85.4% |
24月 | 97.5 | 97.4% | 96.1% | - | - | 69.4% |
备注:对比实施例1和对比实施例2在3月出现沉淀,不再继续检测含量。
从上述实验结果可知,本发明所得的叶黄素口服液稳定性具有显著提高。
实施例生物利用度考察
采用透皮实验仪检测实施例1-3和对比实施例1-3的通过小鼠皮肤速度,从而推算出其
在体内的吸收速度。取小鼠18只大小相似,且生长状况良好,处死后,取背部约1cm2大小的
鼠皮,脱毛后,置于透皮实验仪中,随机分成六组,编号为1-6组,每组三份,分别滴加等量的
由实施例1-3和对比实施例1-3所得的口服液,至上述六个组中,滴加的对应组如下表:
实施例1 | 实施例2 | 实施例3 | 对比实施例1 | 对比实施例2 | 对比实施例3 |
1组 | 2组 | 3组 | 4组 | 5组 | 6组 |
分别在5min、10min、30min、60min、90min、120min、180min检测叶黄素的透过率,检测方
法参考国标GB5009.248-2016中的检测方法及检测条件,结果如下(透过率=透皮后药物量/
投入量*100):
时间 | 实施例1 | 实施例2 | 实施例3 | 对比实施例1 | 对比实施例2 | 对比实施例3 |
5min | 43.5% | 46.5% | 44.8% | 17.2% | 20.2% | 5.2% |
10min | 84.3% | 85.4% | 87.2% | 30.2% | 30.4% | 10.7% |
30min | 98.4% | 98.2% | 92.4% | 38.6% | 40.3% | 18.4% |
60min | 98.1% | 99.4% | 99.5% | 43.4% | 45.4% | 20.3% |
90min | 98.5% | 100.2% | 100.1% | 48.9% | 49.5% | 25.3% |
120min | 99.5% | 99.5% | 99.4% | 53.2% | 55.3% | 30.7% |
180min | 99.1% | 100.1% | 99.2% | 60.1% | 65.7% | 39.5% |
从上述结果分析,本发明所得口服液通透性具有显著效果,从而推断出其体内吸收也具有显著提高。
Claims (8)
1.一种叶黄素口服液的制备方法,由以下步骤组成:
称取适量水,加热至60-80℃,加入二氧化硅,搅拌1-3小时;
加入羊毛醇和叶黄素,继续搅拌1-3小时,保持温度为40-60℃;
(3)加入磷脂,搅拌6-10个小时,保持温度为40-60℃;
(4)加入矫味剂和色素,搅拌混匀,即可。
2.根据权利要求1所述的一种叶黄素口服液制备方法,其特征在于所述的二氧化过加入质量为水的1-5%。
3.根据权利要求2所述的一种叶黄素口服液制备方法,其特征在于所述的二氧化硅粒径小于10微米。
4.根据权利要求1所述的一种叶黄素口服液制备方法,其特征在于所述的羊毛醇与水的质量比为1:200-500。
5.根据权利要求1所述的一种叶黄素口服液制备方法,其特征在于所述的叶黄素与水的质量比为:1:20-40。
6.根据权利要求1所述的一种叶黄素口服液制备方法,其特征在于所述的磷脂与水的质量比为:1:50-150。
7.根据权利要求1所述的一种叶黄素口服液制备方法,其特征在于所述的矫味剂与色素的总质量为口服液总质量的0.1-1%。
8.根据权利要求7所述的一种叶黄素口服液制备方法,其特征在于所述的矫味剂与色素的质量比为1:1。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810398990.7A CN108541947A (zh) | 2018-04-29 | 2018-04-29 | 一种叶黄素口服液的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810398990.7A CN108541947A (zh) | 2018-04-29 | 2018-04-29 | 一种叶黄素口服液的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108541947A true CN108541947A (zh) | 2018-09-18 |
Family
ID=63513155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810398990.7A Pending CN108541947A (zh) | 2018-04-29 | 2018-04-29 | 一种叶黄素口服液的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108541947A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1747658A (zh) * | 2003-03-14 | 2006-03-15 | 巴斯夫公司 | 含有活性化合物的吸附物 |
CN101022786A (zh) * | 2004-09-03 | 2007-08-22 | 南通迈特生物工程有限公司 | 用自乳化制剂释放亲脂性辅酶Q10(CoQ10)及其他膳食组分 |
CN102413813A (zh) * | 2009-03-24 | 2012-04-11 | Adds制药有限责任公司 | 用于口服递送的稳定化的溶解性增强的制剂 |
CN103476432A (zh) * | 2011-01-31 | 2013-12-25 | 瓦克化学股份公司 | 含有脂溶性物质的水溶液的制备方法 |
-
2018
- 2018-04-29 CN CN201810398990.7A patent/CN108541947A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1747658A (zh) * | 2003-03-14 | 2006-03-15 | 巴斯夫公司 | 含有活性化合物的吸附物 |
CN101022786A (zh) * | 2004-09-03 | 2007-08-22 | 南通迈特生物工程有限公司 | 用自乳化制剂释放亲脂性辅酶Q10(CoQ10)及其他膳食组分 |
CN102413813A (zh) * | 2009-03-24 | 2012-04-11 | Adds制药有限责任公司 | 用于口服递送的稳定化的溶解性增强的制剂 |
CN103476432A (zh) * | 2011-01-31 | 2013-12-25 | 瓦克化学股份公司 | 含有脂溶性物质的水溶液的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pu et al. | Encapsulation of lycopene in Chlorella pyrenoidosa: Loading properties and stability improvement | |
Yousefi et al. | Development, characterization and in vitro antioxidant activity of chitosan-coated alginate microcapsules entrapping Viola odorata Linn. extract | |
CN104080438B (zh) | 美白化妆品 | |
Fang et al. | Preparation and evaluation of an encapsulated anthocyanin complex for enhancing the stability of anthocyanin | |
CN103860476B (zh) | 叶黄素水溶性粉末及其制备方法 | |
CN106727432A (zh) | 一种类普鲁士蓝纳米颗粒及其制备方法与应用 | |
WO2002087529A1 (fr) | Compositions pour colorant capillaire utilisees dans la coiffure des cheveux | |
CN101732201A (zh) | 一种还原型辅酶q10精华油及其制备方法 | |
CN104983791A (zh) | 一种含有辅酶q10的保健品及其制备方法 | |
TW201114846A (en) | Spray-dried dye compositions, process for the production and use thereof | |
CN108670882A (zh) | 一种可食用口红及其制备方法 | |
CN107638333A (zh) | 一种茶多酚/壳聚糖微粒及其制备方法 | |
CN107496260A (zh) | 一种含茶多酚复合剂及其制备方法 | |
WO2008029877A1 (fr) | agent anti-vieillissement, agent de blanchiment cutané, agent antioxydant et agent anti-inflammatoire | |
CN108541947A (zh) | 一种叶黄素口服液的制备方法 | |
CN101489528A (zh) | 细胞赋活剂、胶原质产生促进剂、美白剂、抗氧化剂、抗炎症剂、芳香化酶活性促进剂、蛋白酶活性促进剂、皮肤外用剂及食品 | |
CN108524470A (zh) | 一种治疗三阴性乳腺癌的纳米药物系统及其制备方法和应用 | |
CN105168021B (zh) | 一种祛痘美白精华霜及其制备方法 | |
CN106719837A (zh) | 一种植物生长调节剂组合物 | |
CN103271893A (zh) | 番茄红素微型胶囊的制备方法 | |
CN110237105A (zh) | 一种强效抗氧化软胶囊及其制备方法 | |
KR101578464B1 (ko) | 홍국 발효 오일이 함유된 항노화용 화장료 조성물 | |
Zu-Man et al. | Construction of blackberry polysaccharide nano-selenium particles: Structure features and regulation effects of glucose/lipid metabolism in HepG2 cells | |
JP2003155221A (ja) | 皮膚外用剤 | |
CA3086433C (en) | Use of cannabidiol or cannabis extract in preparation of skin whitening products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180918 |
|
WD01 | Invention patent application deemed withdrawn after publication |